Fat content in infant mesenchymal stem cells prospectively associates with childhood adiposity and fasting glucose
Open Access
Abstract
Objective: In human studies, new model systems are needed for improved mechanistic investigation of developmental predisposition for metabolic disease but also to serve as benchmarks in early life prevention or intervention efforts. In this regard, human infant umbilical cord–derived mesenchymal stem cells (MSCs) are an emerging tool. However, long‐term clinical relevance to in vivo markers of metabolic disease is unknown.Methods: In a cohort of 124 mother/child dyads, this study tested the hypothesis that triglyceride content (TG) of infant MSCs undergoing adipogenesis in vitro (MSC‐TG) is associated with in vivo adiposity (percent fat mass) from birth to early childhood and with fasting glucose and insulin in early childhood.Results: MSC‐TG was positively associated with in vivo child adiposity at birth, age 4 to 6 months, and age 4 to 6 years. MSC‐TG was associated with fasting glucose, but not insulin, at 4 to 6 years. Importantly, MSC‐TG explained an additional 13% variance in child adiposity at 4 to 6 years, after accounting for other established birth predictors (weight and percent fat mass at birth) and other established covariates related to child adiposity (e.g., breastfeeding exposure, physical activity).Conclusions: This work demonstrates the strength of the MSC model for predicting offspring metabolic phenotype into childhood, even when considering the important contribution of other early life risk factors.Keywords
Funding Information
- American Diabetes Association (1‐18‐ITCS‐016)
- American Heart Association (14PRE18230008)
- National Institute of Child Health and Human Development (R00 HD097302)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK076648, R01 DK117168)
- National Institutes of Health (UH3 OD023248, UL1TR001082)
This publication has 20 references indexed in Scilit:
- Nicotinamide Promotes Adipogenesis in Umbilical Cord-Derived Mesenchymal Stem Cells and Is Associated with Neonatal Adiposity: The Healthy Start BabyBUMP ProjectPLOS ONE, 2016
- Mesenchymal Stem Cells From Infants Born to Obese Mothers Exhibit Greater Potential for Adipogenesis: The Healthy Start BabyBUMP ProjectDiabetes, 2015
- BMI, total and abdominal fat distribution, and cardiovascular risk factors in school-age childrenPediatric Research, 2015
- Associations of maternal BMI and gestational weight gain with neonatal adiposity in the Healthy Start studyThe American Journal of Clinical Nutrition, 2015
- Maternal Obesity Induces Epigenetic Modifications to Facilitate Zfp423 Expression and Enhance Adipogenic Differentiation in Fetal MiceDiabetes, 2013
- Fasting Plasma Glucose Levels Within the Normoglycemic Range in Childhood as a Predictor of Prediabetes and Type 2 Diabetes in AdulthoodArchives of Pediatrics & Adolescent Medicine, 2010
- Maternal obesity downregulates myogenesis and β-catenin signaling in fetal skeletal muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Metabolic programming: fetal origins of obesity and metabolic syndrome in the adultAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959